NEVIRAPIN Mepha cpr ret 400 mg blist 30 pce
7680663180023
CH-66318
J05AG01
08.03.0.
1 / 3
google
Details
- Product number
- 6631801
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- nevirapinum 400 mg, cellulosum microcristallinum, povidonum K 25, macrogolum 7'000'000, macrogolum 900'000, silica colloidalis anhydrica, magnesii stearas, pro compresso obducto.
Articles (1)
Nevirapin-Mepha 400 mg, Retardtabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 193.35
Specialties list
Yes
Generic
Yes
SL addition date:
01/02/2017
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66318
- Drug name
- Nevirapin-Mepha, Retardtabletten
- Galenic form
- RETT
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 23/11/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NEVIRAPIN Mepha cpr ret 400 mg blist 30 pce
- Description (DE)
- NEVIRAPIN Mepha Ret Tabl 400 mg Blist 30 Stk
- Market launch
- 23/11/2016
- Narcotic (BTM)
- No